Found 16 matching trials
Dose Ranging Study of Indacaterol in Japanese Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The study was designed to obtain data about the efficacy and safety of 3 do...
Show More Location
Novartis Investigative site
Learn More & Join Trial
Study to Determine the Onset of Action of Indacaterol in Patients With Moderate to Severe Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study will evaluate the onset of action of indacaterol (150 and 300 µg...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Efficacy and Safety of Single Doses of Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) Compared to Placebo in Patients With Persistent Asthma PHASE2 The study is designed to obtain safety and efficacy data on three dose leve...
Show More Location
Colorado Allergy and Asthma Centres, P.C.
Learn More & Join Trial
Safety, Tolerability and Efficacy of Indacaterol in Patients With Moderate-to-severe Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study evaluated the 1 year safety, tolerability and efficacy of indaca...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Safety of Indacaterol in Patients (≥ 12 Years) With Moderate to Severe Persistent Asthma PHASE3 This study was designed to assess the safety of indacaterol (300 µg and 600...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Dose Ranging Study for Indacaterol in Japanese Asthma Patients PHASE2 This study was designed to provide data about the safety and efficacy of 3 ...
Show More Location
Novartis Investigative Site
Learn More & Join Trial
Confirmatory Study of Indacaterol in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study is designed to collect long term safety data of indacaterol (300...
Show More Location
Novartis Investigator Site
Learn More & Join Trial
Indacaterol Delivered Via a Single Dose Dry Powder Inhaler (SDDPI) in Chronic Obstructive Pulmonary Disease (COPD) PHASE2 The study is designed to obtain safety and efficacy data on three dose leve...
Show More Learn More & Join Trial
Cardiac Safety of Indacaterol PHASE1 This study compares the cardiac safety of inhaled indacaterol with that of ...
Show More Location
Novartis investigative site
Learn More & Join Trial
Study of Indacaterol Dosed in the Evening in Patients With Chronic Obstructive Pulmonary Disease (COPD) PHASE3 This study was conducted to provide detailed information on the efficacy of...
Show More Location
Novartis Investigative Site
Learn More & Join Trial